About Geneoscopy
Geneoscopy is a company based in St. Louis (United States) founded in 2015. Geneoscopy has raised $218.95 million across 6 funding rounds from investors including LabCorp, Mercy Health and Bio Rad. Geneoscopy offers products and services including seRNA Technology Platform and Stool-based Screening Test. Geneoscopy operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Geneoscopy Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$218.95 M (USD)
in 6 rounds
-
Latest Funding Round
$105 M (USD), Series C
Jan 08, 2025
-
Investors
LabCorp
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Geneoscopy
Geneoscopy offers a comprehensive portfolio of products and services, including seRNA Technology Platform and Stool-based Screening Test.
Noninvasive platform for detecting colorectal cancer and GI diseases
Test for early detection of gastrointestinal conditions using RNA analysis
People of Geneoscopy
Unlock access to complete
Unlock access to complete
Funding Insights of Geneoscopy
Geneoscopy has successfully raised a total of $218.95M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $105 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Geneoscopy
Geneoscopy has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include LabCorp, Mercy Health and Bio Rad.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Petrichor is engaged in supporting healthcare innovation through investments.
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on early-stage life science companies
|
Locked | Locked | Locked |
Investor details for Geneoscopy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Geneoscopy
Investment portfolio details for Geneoscopy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Geneoscopy
Detailed financials for Geneoscopy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Geneoscopy Comparisons
Peer comparison for Geneoscopy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Geneoscopy
Geneoscopy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
Detailed competitors of Geneoscopy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Geneoscopy
Complete news archive for Geneoscopy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geneoscopy
Geneoscopy was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Geneoscopy is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Geneoscopy is a funded company, having raised a total of $218.95M across 6 funding rounds to date.
Geneoscopy was founded in 2015 and is headquartered in St. Louis, United States. Non-invasive diagnostic tests for colorectal cancer are developed within the biotechnology sector. Stool samples are examined for a panel of mRNA biomarkers through a proprietary algorithm to identify the disease. The primary assay is designed for screening patients potentially needing colonoscopy procedures, with operations centered on advancing biomarker-based diagnostics.
Geneoscopy's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
Geneoscopy offers seRNA Technology Platform and Stool-based Screening Test.
Geneoscopy has 17 investors. Key investors include LabCorp, Mercy Health, Bio Rad, Arch Grants, and Petrichor.